Results for tag: "Bromodomain Containing Protein 4"

Bromodomain Containing Protein 4 (BRD4) is a protein that plays a role in the regulation of gene expression. It is a target for oncology drugs, as it is involved in the development of cancer. BRD4 inhibitors are a type of drug that can be used to treat cancer by blocking the activity of BRD4, thus preventing the growth and spread of cancer cells. BRD4 inhibitors have been studied in a variety of cancers, including breast, lung, and prostate cancer. BRD4 inhibitors are a promising new class of drugs for the treatment of cancer. They have the potential to be more effective than existing treatments, as they target the underlying cause of cancer rather than just the symptoms. Several companies are developing BRD4 inhibitors, including AstraZeneca, Merck, and Novartis. These companies are working to develop drugs that can be used to treat a variety of cancers. Show Less Read more